India levofloxacin market is expected
to grow at a steady rate during the forecast period. Surging government
initiatives with an intention of increasing awareness regarding diagnosis and
treatment of pneumonia and similar infections is further expected to boost the
demand through FY2026. High burden of antibiotic-resistant infections is
further predicted to increase the product demand in the forthcoming years,
thereby bolstering the market growth.
The India levofloxacin
market is
segmented based on strength, application, form, route of administration,
source, distribution channel, end user, company, and region. Based on form, the
market is segmented into tablet, capsule and injection. The injection segment dominated
the market until FY2020 and is further expected to maintain its leading
position during the forecast period as it is an injectable drug which is also
marketed in tablet form. This medication is given by injection
into a vein as directed by your doctor, usually once a day over at least 1
hour. Also, the tablet segment is anticipated to register high growth in the
next 5 years which is attributable to various factors like, safety,
effectiveness and patient compliance. In addition to this, properties such as
high stability of tablets are further boosting the segmental growth in the
years to come.
The major players
operating in the India levofloxacin market are Dr. Reddy’s Laboratories Ltd., Aden
Healthcare Pvt. Ltd., Allenge India Pharmaceuticals Pvt. Ltd., Alna Biotech
Pvt. Ltd., Bestochem Formulations India Ltd., Glenmark Pharmaceuticals Ltd., Lupin
Ltd., Cadila Healthcare Ltd., Valentis Pharma Pvt. Ltd., Pax Healthcare Pvt.
Ltd. and others. Major companies are developing advanced technologies,
receiving approvals from regulatory bodies, and launching new products in order
to stay competitive in the market. Other inorganic growth strategies include
mergers & acquisitions, joint ventures, and new product developments in
order to sustain themselves amidst fierce competition.
Years considered for this report:
Historical Years: FY2016-FY2019
Base Year: FY2020
Estimated Year: FY2021
Forecast Period: FY2022–FY2026
Objective of the
Study:
- To analyze and estimate the market size of India
levofloxacin market from FY2016 to FY2019.
- To estimate and forecast the market size of India
levofloxacin market from FY2020 to FY2026 and growth rate until FY2026.
- To classify and forecast India levofloxacin market
based on strength, application, form, route of administration, source,
distribution channel, end user, company, and regional distribution.
- To identify dominant region or segment in the India
levofloxacin market.
- To identify drivers and challenges for India levofloxacin
market.
- To examine competitive developments such as
expansions, new product launches, mergers & acquisitions, etc., in India
levofloxacin market.
- To identify and analyze the profile of leading
players operating in India levofloxacin market.
- To identify key sustainable strategies adopted
by market players in India levofloxacin market.
Click here to download the sample
TechSci Research performed both primary as well as
exhaustive secondary research for this study. Initially, TechSci Research
sourced a list of manufacturers across the globe. Subsequently, TechSci
Research conducted primary research surveys with the identified companies.
While interviewing, the respondents were also enquired about their competitors.
Through this technique, TechSci Research could include the manufacturers which
could not be identified due to the limitations of secondary research. TechSci
Research analyzed the manufacturers, distribution channels and presence of all
major players across the globe.
TechSci Research calculated the market size of India levofloxacin market using a bottom-up approach, wherein data for various end-user
segments was recorded and forecast for the future years. TechSci Research
sourced these values from the industry experts and company representatives and
externally validated through analyzing historical data of these product types
and applications for getting an appropriate, overall market size. Various
secondary sources such as company websites, news articles, press releases,
company annual reports, investor presentations and financial reports were also studied
by TechSci Research.
Key Target Audience:
- Levofloxacin manufacturers/
suppliers/ distributors
- Market research and
consulting firms
- Government bodies such as
regulating authorities and policy makers
- Organizations, forums and
alliances related to levofloxacin
The study is useful in providing answers
to several critical questions that are important for the industry stakeholders
such as manufacturers, suppliers and partners, end users, etc., besides
allowing them in strategizing investments and capitalizing on market
opportunities.
Report Scope:
In this report, India levofloxacin
market has been segmented into following categories, in addition to the
industry trends which have also been detailed below:
- India Levofloxacin Market, By Strength:
- 250 mg Tablets
- 500 mg Tablets
- 750 mg Tablets
- India Levofloxacin Market, By Application:
- Pneumonia
- Skin
Infection
- Kidney
Infection
- Bladder
Infection
- Others
- India Levofloxacin Market, By Form:
- India Levofloxacin Market, By Route of
Administration:
- India Levofloxacin Market, By Source:
- In-house
- Contract Manufacturing Organizations
- India Levofloxacin Market, By Distribution Channel:
- India Levofloxacin Market, By End User:
- India Levofloxacin Market, By Region:
Competitive
Landscape
Company Profiles: Detailed analysis of the major
companies present in India levofloxacin market.
Available
Customizations:
With the given market data, TechSci
Research offers customizations according to a company’s specific needs. The
following customization options are available for the report:
Company Information
- Detailed
analysis and profiling of additional market players (up to five).
India levofloxacin market
is an upcoming report to be released soon. If you wish an early delivery of
this report or want to confirm the date of release, please contact us at [email protected]